US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
ARQT holding history
Arcutis Biotherapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARQT overviewAll 13F holders of ARQTFull Q2 2026 holdings
- Shares (Q2 2026)
- 141
- Value
- $3.70K
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 141 | $3.70K | <0.1% | −1−0.7% | Reduced | Holders |
| Q1 2026 | 142 | $3.35K | <0.1% | −119−45.6% | Reduced | Holders |
| Q4 2025 | 261 | $7.58K | <0.1% | +261 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −62−100.0% | Sold out | Holders |
| Q2 2025 | 62 | $869 | <0.1% | −57−47.9% | Reduced | Holders |
| Q1 2025 | 119 | $1.86K | <0.1% | +95+395.8% | Added | Holders |
| Q4 2024 | 24 | $334 | <0.1% | +24 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −80−100.0% | Sold out | Holders |
| Q2 2023 | 80 | $762 | <0.1% | +80 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −480−100.0% | Sold out | Holders |
| Q4 2022 | 480 | $7.10K | <0.1% | +428+823.1% | Added | Holders |
| Q3 2022 | 52 | $1.00K | <0.1% | −233−81.8% | Reduced | Holders |
| Q2 2022 | 285 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 285 | $5.00K | <0.1% | +285 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −114−100.0% | Sold out | Holders |
| Q3 2021 | 114 | $3.00K | <0.1% | +22+23.9% | Added | Holders |
| Q2 2021 | 92 | $3.00K | <0.1% | +92 | New | Holders |